Akèy › Sindrom Bronchiolit Obliteran › North Carolina
Etid klinik pou Sindrom Bronchiolit Obliteran nan North Carolina
7 etid pou Sindrom Bronchiolit Obliteran ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
- Duke Eye Center - Ophthalmology, Durham
Ap rekriteFaz 3
Laj 10 a 65 · Tout sèks · Mizajou Sep 21, 2026 · NCT07395232A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
- Levine Cancer Institute, Charlotte
- Duke Cancer Center, Durham
Ap rekriteFaz 2
Laj 2 a 17 · Tout sèks · Mizajou Sep 15, 2026 · NCT07124078A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- Wake Forest Baptist Medical Center, Winston-Salem
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06585774Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- University of North Carolina at Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05919511A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
- University of North Carolina At Chapel Hill, Chapel Hill
- Levine Cancer Institute, Charlotte
- Duke University Medical Center, Durham
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06615050Ruxolitinib Plus Fostamatinib for Steroid Refractory cGvHD
- Duke, Durham
Ap rekriteFaz 1
Laj 18 a 80 · Tout sèks · Mizajou Jan 22, 2026 · NCT06233110A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Levine Cancer Institute, Charlotte
- Duke University Hospital, Durham
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Dec 15, 2025 · NCT06619561Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.